150 related articles for article (PubMed ID: 27449291)
1. Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.
Kim JH; Jung YJ; Choi B; Lee NL; Lee HJ; Kwak SY; Kwon Y; Na Y; Lee YS
Oncotarget; 2016 Aug; 7(33):53178-53190. PubMed ID: 27449291
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of lung cancer cells by altered dimerization of HSP27.
Choi B; Choi SK; Park YN; Kwak SY; Lee HJ; Kwon Y; Na Y; Lee YS
Oncotarget; 2017 Dec; 8(62):105372-105382. PubMed ID: 29285257
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers.
Gibert B; Hadchity E; Czekalla A; Aloy MT; Colas P; Rodriguez-Lafrasse C; Arrigo AP; Diaz-Latoud C
Oncogene; 2011 Aug; 30(34):3672-81. PubMed ID: 21423207
[TBL] [Abstract][Full Text] [Related]
4. In silico evaluation of human small heat shock protein HSP27: homology modeling, mutation analyses and docking studies.
Fossa P; Cichero E
Bioorg Med Chem; 2015 Jul; 23(13):3215-20. PubMed ID: 25999205
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.
Hwang SY; Kwak SY; Kwon Y; Lee YS; Na Y
Eur J Med Chem; 2017 Oct; 139():892-900. PubMed ID: 28869891
[TBL] [Abstract][Full Text] [Related]
6. Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers.
Yoo H; Choi SK; Lee J; Park SH; Park YN; Hwang SY; Shin JH; Na Y; Kwon Y; Lee HJ; Lee YS
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33925114
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
[TBL] [Abstract][Full Text] [Related]
8. Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance.
Choi SH; Lee YJ; Seo WD; Lee HJ; Nam JW; Lee YJ; Kim J; Seo EK; Lee YS
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1196-205. PubMed ID: 21353161
[TBL] [Abstract][Full Text] [Related]
9. HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target.
Arrigo AP; Gibert B
Curr Mol Med; 2012 Nov; 12(9):1151-63. PubMed ID: 22804238
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
Lee CH; Hong HM; Chang YY; Chang WW
Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
[TBL] [Abstract][Full Text] [Related]
11. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
Wang X; Chen M; Zhou J; Zhang X
Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
[TBL] [Abstract][Full Text] [Related]
12. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
Belkacemi L; Hebb MO
Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
[TBL] [Abstract][Full Text] [Related]
13. The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.
Hirakawa H; Fujisawa H; Masaoka A; Noguchi M; Hirayama R; Takahashi M; Fujimori A; Okayasu R
Cancer Med; 2015 Mar; 4(3):426-36. PubMed ID: 25582113
[TBL] [Abstract][Full Text] [Related]
14. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
Schaefer S; Svenstrup TH; Guerra B
PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
[TBL] [Abstract][Full Text] [Related]
15. HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin.
Cui Y; Wu W; Zhou Y; Xie Q; Liu T; Jin J; Liu K
Future Oncol; 2013 Mar; 9(3):411-8. PubMed ID: 23469976
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells.
Asada Y; Tsuruta M; Okabayashi K; Shigeta K; Ishida T; Shimada T; Suzumura H; Koishikawa K; Akimoto S; Hasegawa H; Kitagawa Y
Anticancer Res; 2021 Mar; 41(3):1283-1290. PubMed ID: 33788719
[TBL] [Abstract][Full Text] [Related]
18. Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation.
Jin HO; Hong SE; Kim JY; Kim MR; Chang YH; Hong YJ; Lee JK; Park IC
Oncol Rep; 2019 May; 41(5):3119-3126. PubMed ID: 30864724
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.
Sawai A; Chandarlapaty S; Greulich H; Gonen M; Ye Q; Arteaga CL; Sellers W; Rosen N; Solit DB
Cancer Res; 2008 Jan; 68(2):589-96. PubMed ID: 18199556
[TBL] [Abstract][Full Text] [Related]
20. HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancer.
O'Connell BC; O'Callaghan K; Tillotson B; Douglas M; Hafeez N; West KA; Stern H; Ali JA; Changelian P; Fritz CC; Palombella VJ; McGovern K; Kutok JL
PLoS One; 2014; 9(12):e115228. PubMed ID: 25542032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
